Viridos
VC Fund
La Jolla, United States
Viridos is a VC fund in La Jolla focused on Genetics and Health Care. Viridos develops genomic-driven solutions to address global energy and environmental challenges.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Viridos invests in
Stages Viridos invests in
Countries Viridos invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
David C. Kiernan
|
|||
Fernanda Gandara
|
|||
Hamilton Smith
|
|||
James Ferry
|
|||
J. Craig Venter
|
|||
| See all 8 contacts → | |||
Investment Focus
Industry
- Genetics 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Health Diagnostics 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
David C. Kiernan
Founder & Board of Directors
|
Founder & Board of Directors | Total investments: 0 | Find email | |
|
Fernanda Gandara
SVP, Business Development
|
SVP, Business Development | Total investments: 0 | Find email | |
|
Hamilton Smith
Co - Founder & Co - Chief Scientific Officer
|
Co - Founder & Co - Chief Scientific Officer | Total investments: 0 | Find email | |
|
James Ferry
Science Consultant
|
Science Consultant | Total investments: 0 | Find email | |
|
J. Craig Venter
Founder & CEO
|
Founder & CEO | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Human Longevity
|
Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomicpowered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California. | $80M / Series A / Mar 04, 2014 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Viridos invest in?
Viridos invests primarily in Genetics, Health Care and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Viridos?
Public channels for Viridos include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Viridos?
The team at Viridos includes David C. Kiernan (Founder & Board of Directors), Fernanda Gandara (SVP, Business Development) and Hamilton Smith (Co - Founder & Co - Chief Scientific Officer), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
